TRDA 8-K 2026-10-14

Entrada Therapeutics, Inc. (TRDA) 8-K dated 2026-10-14 — accession 0001689375-26-000057. This URL is the filing, not the TRDA hub.

Entrada Therapeutics, Inc. (TRDA) is a biotechnology company listed on US.

Entrada Therapeutics, Inc. filed a 8-K on 2026-10-14. Accession 0001689375-26-000057.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TRDA revenue for 2025-12-31 was $25.4M. Net income was -$143.8M. Revenue was down 87.9% from 2024-12-31 to 2025-12-31. TRDA currently screens at market cap $274.4M.

Not investment advice. The TRDA SEC hub lists recent forms. The stock page is the research view.